EP 2755968 A1 20140723 - NOVEL POLYMORPHIC FORM OF RALTEGRAVIR POTASSIUM
Title (en)
NOVEL POLYMORPHIC FORM OF RALTEGRAVIR POTASSIUM
Title (de)
NEUE POLYMORPHE FORM VON RALTEGRAVIR-KALIUM
Title (fr)
NOUVELLE FORME POLYMORPHE DU RALTÉGRAVIR POTASSIUM
Publication
Application
Priority
- EP 11007545 A 20110916
- EP 2012067644 W 20120910
- EP 12756733 A 20120910
Abstract (en)
[origin: WO2013037731A1] The invention relates to a method for producing a polymorphic form IV of raltegravir potassium. The method is characterized in that raltegravir potassium, as the starting material, is hydrated, said starting material being brought into contact with at least one fluid comprising water during a reaction time, whereby the starting material is hydrated.
IPC 8 full level
C07D 413/12 (2006.01); A61K 31/513 (2006.01); A61P 31/18 (2006.01)
CPC (source: EP)
A61P 31/18 (2017.12); C07D 413/12 (2013.01)
Citation (search report)
See references of WO 2013037731A1
Citation (third parties)
Third party :
WO 2011123754 A1 20111006 - TEVA PHARMA [IL], et al
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2012067644 W 20120910; EP 12756733 A 20120910